The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Uric acid and cardiovascular disease: A clinical review
Open accessAbstract
Uric acid, the end-product of purine metabolism in humans, is not only a cause of gout, but also may play roles in developing cardiovascular diseases such as hypertension, atrial fibrillation, chronic kidney disease, heart failure, coronary artery disease, and cardiovascular death. Several clinical investigations have reported serum uric acid as a predictive marker for cardiovascular outcomes. Although the causal relationship of hyperuricemia to cardiovascular diseases remains controversial, there has been a growing interest in uric acid because of the increased prevalence of hyperuricemia worldwide. This review article summarizes current evidence concerning the relation between hyperuricemia and cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Serum Uric Acid and Cardiovascular Mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
Fang, J., & Alderman, M. H. (2000) · JAMA · doi:10.1001/jama.283.18.2404 · Cited by 1,513
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Culleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00003 · Cited by 1,282
Purine-Rich Foods, Dairy and Protein Intake, and the Risk of Gout in Men
Choi, H. K., Atkinson, K., Karlson, E. W., Willett, W., & Curhan, G. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035700 · Cited by 1,178
Dalbeth, N., Merriman, T. R., & Stamp, L. K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00346-9 · Cited by 1,087
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
White, W. B., Saag, K. G., Becker, M. A., Borer, J. S., Gorelick, P. B., Whelton, A., Hunt, B., Castillo, M., & Gunawardhana, L. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710895 · Cited by 909
Kang, D.-H., Park, S.-K., Lee, I.-K., & Johnson, R. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050572 · Cited by 882
Niskanen, L. K., Laaksonen, D. E., Nyyssönen, K., Alfthan, G., Lakka, H.-M., Lakka, T. A., & Salonen, J. T. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.14.1546 · Cited by 666
Uric acid and chronic kidney disease: which is chasing which?
Johnson, R. J., Nakagawa, T., Jalal, D., Sanchez-Lozada, L. G., Kang, D.-H., & Ritz, E. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft029 · Cited by 654
Uric Acid Is a Risk Factor for Myocardial Infarction and Stroke: The Rotterdam Study
Bos, M. J., Koudstaal, P. J., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2006) · Stroke · doi:10.1161/01.str.0000221716.55088.d4 · Cited by 615
Anker, S. D., Doehner, W., Rauchhaus, M., Sharma, R., Francis, D., Knosalla, C., Davos, C. H., Cicoira, M., Shamim, W., Kemp, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065637.10517.a0 · Cited by 593
George, J., Carr, E., Davies, J., Belch, J. J. F., & Struthers, A. (2006) · Circulation · doi:10.1161/circulationaha.106.651117 · Cited by 569
Doehner, W., Schoene, N., Rauchhaus, M., Leyva-Leon, F., Pavitt, D. V., Reaveley, D. A., Schuler, G., Coats, A. J. S., Anker, S. D., & Hambrecht, R. (2002) · Circulation · doi:10.1161/01.cir.0000017502.58595.ed · Cited by 565
Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid
Davies, K. J. A., Sevanian, A., Muakkassah-Kelly, S. F., & Hochstein, P. (1986) · Biochemical Journal · doi:10.1042/bj2350747 · Cited by 558
Verdecchia, P., Schillaci, G., Reboldi, G., Santeusanio, F., Porcellati, C., & Brunetti, P. (2000) · Hypertension · doi:10.1161/01.hyp.36.6.1072 · Cited by 558
Physiological functions and pathogenic potential of uric acid: A review
El Ridi, R., & Tallima, H. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2017.03.003 · Cited by 542
Masuo, K., Kawaguchi, H., Mikami, H., Ogihara, T., & Tuck, M. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000091371.53502.d3 · Cited by 516
Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure
Farquharson, C. A. J., Butler, R., Hill, A., Belch, J. J. F., & Struthers, A. D. (2002) · Circulation · doi:10.1161/01.cir.0000022140.61460.1d · Cited by 504
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Badve, S. V., Pascoe, E. M., Tiku, A., Boudville, N., Brown, F. G., Cass, A., Clarke, P., Dalbeth, N., Day, R. O., de Zoysa, J. R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915833 · Cited by 473
Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review
Sharaf El Din, U. A. A., Salem, M. M., & Abdulazim, D. O. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2016.11.004 · Cited by 417
Lehto, S., Niskanen, L., Rönnemaa, T., & Laakso, M. (1998) · Stroke · doi:10.1161/01.str.29.3.635 · Cited by 411
Impact of Oxypurinol in Patients With Symptomatic Heart Failure
Hare, J. M., Mangal, B., Brown, J., Fisher, C., Freudenberger, R., Colucci, W. S., Mann, D. L., Liu, P., Givertz, M. M., & Schwarz, R. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.068 · Cited by 392
Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K. K., Ioannidis, P. A., Campbell, H., & Theodoratou, E. (2017) · BMJ · doi:10.1136/bmj.j2376 · Cited by 385
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kimura, K., Hosoya, T., Uchida, S., Inaba, M., Makino, H., Maruyama, S., Ito, S., Yamamoto, T., Tomino, Y., Ohno, I., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.028 · Cited by 383
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
Doria, A., Galecki, A. T., Spino, C., Pop-Busui, R., Cherney, D. Z., Lingvay, I., Parsa, A., Rossing, P., Sigal, R. J., Afkarian, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916624 · Cited by 377
New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity
Furuhashi, M. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00378.2020 · Cited by 361
Mackenzie, I. S., Ford, I., Nuki, G., Hallas, J., Hawkey, C. J., Webster, J., Ralston, S. H., Walters, M., Robertson, M., De Caterina, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32234-0 · Cited by 352
Noman, A., Ang, D. S., Ogston, S., Lang, C. C., & Struthers, A. D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60391-1 · Cited by 348
Wang, J., Qin, T., Chen, J., Li, Y., Wang, L., Huang, H., & Li, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114259 · Cited by 341
URic Acid and Risk Of Heart Failure: A Systematic Review and Meta-Analysis
Huang, H., Huang, B., Li, Y., Huang, Y., Li, J., Yao, H., Jing, X., Chen, J., & Wang, J. (2014) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft132 · Cited by 339
Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents
Soletsky, B., & Feig, D. I. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.196980 · Cited by 334
Childhood Uric Acid Predicts Adult Blood Pressure: The Bogalusa Heart Study
Alper, A. B., Chen, W., Yau, L., Srinivasan, S. R., Berenson, G. S., & Hamm, L. L. (2005) · Hypertension · doi:10.1161/01.hyp.0000150783.79172.bb · Cited by 314
Uric Acid and Cardiovascular Events: A Mendelian Randomization Study
Kleber, M. E., Delgado, G., Grammer, T. B., Silbernagel, G., Huang, J., Krämer, B. K., Ritz, E., & März, W. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070660 · Cited by 299
Givertz, M. M., Anstrom, K. J., Redfield, M. M., Deswal, A., Haddad, H., Butler, J., Tang, W. H. W., Dunlap, M. E., LeWinter, M. M., Mann, D. L., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.014536 · Cited by 296
Association of Uric Acid With Change in Kidney Function in Healthy Normotensive Individuals
Bellomo, G., Venanzi, S., Verdura, C., Saronio, P., Esposito, A., & Timio, M. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.01.019 · Cited by 260
Major, T. J., Topless, R. K., Dalbeth, N., & Merriman, T. R. (2018) · BMJ · doi:10.1136/bmj.k3951 · Cited by 246
Hyperuricemia and endothelial function: From molecular background to clinical perspectives
Maruhashi, T., Hisatome, I., Kihara, Y., & Higashi, Y. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.10.007 · Cited by 242
Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk
Mercuro, G., Vitale, C., Cerquetani, E., Zoncu, S., Deidda, M., Fini, M., & Rosano, G. M. C. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.06.032 · Cited by 223
Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies
Zuo, T., Liu, X., Jiang, L., Mao, S., Yin, X., & Guo, L. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0379-z · Cited by 178
Kanji, T., Gandhi, M., Clase, C. M., & Yang, R. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0047-z · Cited by 174
Kojima, S., Sakamoto, T., Ishihara, M., Kimura, K., Miyazaki, S., Yamagishi, M., Tei, C., Hiraoka, H., Sonoda, M., Tsuchihashi, K., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.04.007 · Cited by 169
Li, X., Meng, X., He, Y., Spiliopoulou, A., Timofeeva, M. N., Wei, W., Gifford, A., Yang, T., Varley, T., Tzoulaki, I., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002937 · Cited by 150
Association between serum uric acid and atrial fibrillation: A systematic review and meta-analysis
Tamariz, L. J., Hernandez, F., Bush, A. L., Palacio, A., & Hare, J. M. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.04.003 · Cited by 135
Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.
White, J., Sofat, R., Hemani, G., Shah, T., Engmann, J., Dale, C., Shah, S., Kruger, F. A., Giambartolomei, C., Swerdlow, D. I., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00386-1 · Cited by 132
Hyperuricemia and Incident Heart Failure
Krishnan, E. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.797662 · Cited by 127
Jing, J., Kielstein, J. T., Schultheiß, U. T., Sitter, T., Titze, S. I., Schäeffner, E., McAdams‐DeMarco, M., Kronenberg, F., Eckardt, K., Köttgen, A., et al. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu352 · Cited by 126
Hyperuricemia predicts adverse outcomes in patients with heart failure
Hamaguchi, S., Furumoto, T., Tsuchihashi‐Makaya, M., Goto, K., Goto, D., Yokota, T., Kinugawa, S., Yokoshiki, H., Takeshita, A., & Tsutsui, H. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.05.002 · Cited by 125
Sánchez‐Lozada, L. G., Tapia, E., Soto, V., Ávila-Casado, C., Franco, M., Zhao, L., & Johnson, R. J. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm783 · Cited by 120
Prasad, M., Matteson, E. L., Herrmann, J., Gulati, R., Rihal, C. S., Lerman, L. O., & Lerman, A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08436 · Cited by 110
Tanaka, A., Taguchi, I., Teragawa, H., Ishizaka, N., Kanzaki, Y., Tomiyama, H., Sata, M., Sezai, A., Eguchi, K., Kato, T., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003095 · Cited by 103
Self-citationSaito, Y., Kobayashi, Y., Fujii, K., Sonoda, S., Tsujita, K., Hibi, K., Morino, Y., Okura, H., Ikari, Y., & Honye, J. (2019) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-019-00625-6 · Cited by 101
Self-citationHiggins, P., Walters, M. R., Murray, H. M., McArthur, K., McConnachie, A., Lees, K. R., & Dawson, J. (2014) · Heart · doi:10.1136/heartjnl-2014-305683 · Cited by 96
Uric acid and cardiometabolic diseases
Lee, S. J., Oh, B. K., & Sung, K. (2020) · Clinical Hypertension · doi:10.1186/s40885-020-00146-y · Cited by 84
Xu, X. Y., Hu, X., Lu, Z., Zhang, P., Zhao, L., Wessale, J. L., Bache, R. J., & Chen, Y. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.06.006 · Cited by 81
Sakabe, M., Fujiki, A., Sakamoto, T., Nakatani, Y., Mizumaki, K., & Inoue, H. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02356.x · Cited by 70
Wada, T., Hosoya, T., Honda, D., Sakamoto, R., Narita, K., Sasaki, T., Okui, D., & Kimura, K. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1530-1 · Cited by 62
Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis
Luo, Q., Xia, X., Li, B., Lin, Z., Yu, X., & Huang, F. (2019) · BMC Nephrology · doi:10.1186/s12882-018-1143-7 · Cited by 58
Suzuki, S., Kaikita, K., Yamamoto, E., Jinnouchi, H., & Tsujita, K. (2020) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-020-00720-z · Cited by 54
Contemporary coronary drug-eluting and coated stents: a mini-review
Saito, Y., & Kobayashi, Y. (2020) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-020-00731-w · Cited by 48
Self-citationAndo, K., Takahashi, H., Watanabe, T., Daidoji, H., Otaki, Y., Nishiyama, S., Arimoto, T., Shishido, T., Miyashita, T., Miyamoto, T., et al. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.33951 · Cited by 45
Uric Acid Level and Prevalence of Atrial Fibrillation in a Japanese General Population of 285,882
Kawasoe, S., Kubozono, T., Yoshifuku, S., Ojima, S., Oketani, N., Miyata, M., Miyahara, H., Maenohara, S., & Ohishi, M. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0766 · Cited by 41
Tanaka, A., Kawaguchi, A., Tomiyama, H., Ishizu, T., Matsumoto, C., Higashi, Y., Takase, B., Suzuki, T., Ueda, S., Yamazaki, T., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.06.017 · Cited by 34
Self-citationSaito, Y., Kitahara, H., Nakayama, T., Fujimoto, Y., & Kobayashi, Y. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.45179 · Cited by 31
Self-citationSegal, M. S., Srinivas, T. R., Mohandas, R., Shuster, J. J., Wen, X., Whidden, E. M., Tantravahi, J., & Johnson, R. J. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.05.009 · Cited by 28
Increased plasma xanthine oxidoreductase activity deteriorates coronary artery spasm
Watanabe, K., Shishido, T., Otaki, Y., Watanabe, T., Sugai, T., Toshima, T., Takahashi, T., Yokoyama, M., Kinoshita, D., Murase, T., et al. (2018) · Heart and Vessels · doi:10.1007/s00380-018-1207-4 · Cited by 28
Mori, N., Saito, Y., Saito, K., Matsuoka, T., Tateishi, K., Kadohira, T., Kitahara, H., Fujimoto, Y., & Kobayashi, Y. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.12.043 · Cited by 12
Self-citationOkuya, Y., Saito, Y., Takahashi, T., & Kishi, K. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.09.004 · Cited by 10
Self-citationSaito, Y., Mori, N., Murase, T., Nakamura, T., Akari, S., Saito, K., Matsuoka, T., Tateishi, K., Kadohira, T., Kitahara, H., et al. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01730-w · Cited by 8
Self-citation
Cited by
Low serum albumin: A neglected predictor in patients with cardiovascular disease
Manolis, A. A., Manolis, T. A., Melita, H., Mikhailidis, D. P., & Manolis, A. S. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.05.004 · Cited by 353
Metadata
- Authors
- Saito, Y., Tanaka, A., Node, K., & Kobayashi, Y.
- Venue
- Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 78
- Issue
- 1
- Pages
- 51-57
- ISSN
- 0914-5087 (ISSN-L)
- OpenAlex
- W3116221844
- Cited by
- 374
- References
- 68
- FWCI
- 18.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.